SCHEMBL2410201

SCHEMBL2410201

CC(C)(C)C(NC(=O)C1CCCCC1)c1ccc(C(=O)NO)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 7/20 0.52
HPGD P15428 2/20 0.50
ALDH1A1 P00352 1/20 0.50
RAB9A P51151 1/20 0.50
POLB P06746 1/20 0.48
HDAC1 Q13547 5/20 0.46
HDAC8 Q9BY41 4/20 0.46
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
RECQL P46063 1/20 0.44
ADAM17 P78536 1/20 0.44
KMT2A Q03164 1/20 0.44
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTT P42858 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC11 Q96DB2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2413157 0.99 HDAC6 (0.50) HDAC6HPGDALDH1A1RAB9APOLB
SCHEMBL12280140 0.86 HDAC6 (0.43) HDAC6POLBHDAC1HDAC8KMT2A
SCHEMBL2407120 0.83 HDAC1 (0.57) HDAC6HPGDALDH1A1RAB9APOLB
SCHEMBL2407873 0.83 HDAC1 (0.57) HDAC6HPGDALDH1A1RAB9APOLB
SCHEMBL2407826 0.83 POLB (0.70) HDAC6HPGDALDH1A1POLBHDAC1
SCHEMBL2406624 0.83 POLB (0.70) HDAC6HPGDALDH1A1POLBHDAC1
SCHEMBL2408877 0.82 HDAC1 (0.58) HDAC6HPGDALDH1A1RAB9APOLB
SCHEMBL2412018 0.81 POLB (0.72) HDAC6HPGDPOLBHDAC1HDAC8
SCHEMBL2405355 0.80 HDAC6 (0.48) HDAC6RAB9AHDAC1HDAC8LMNA
SCHEMBL2406952 0.79 HPGD (0.68) HDAC6HPGDPOLBHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9382197-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-07-05 US disclosed
US-9382197-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-07-05 US disclosed
US-20140275093-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-09-18 US disclosed
US-20140275093-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-09-18 US disclosed
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 US disclosed
WO-2011106632-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 WO disclosed
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275093-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC10, HDAC1 HDAC6 1/4885HPGD 1954/4885ALDH1A1 1696/4885
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC10, HDAC1 HDAC6 1/4885HPGD 1954/4885ALDH1A1 1696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.